AstraZeneca has released phase II clinical trial data from its COVID-19 vaccine. This data indicates that a similar immune response is generated in all participants, including those both under and over 70 years of age. The vaccine, known as AZD1222, was administered to 200 people aged 70 years or older, though the study excluded individuals with substantial comorbidities or clinical frailty. More comprehensive phase III data will be released by the end of the year. Overall, packaging is a crucial element of clinical trial distribution. At Yourway, our primary and secondary packaging capabilities integrate seamlessly with our storage, distribution, and premium courier services to enhance supply chain efficiency and facilitate shorter lead times compared to other clinical services and logistics companies.
6681 Snowdrift Road
Toll Free:
Fax:
Email:
